← Back to headlines
Canada Approves First Generic Version of Novo's Ozempic
Canada has officially approved the first generic version of Novo Nordisk's popular diabetes drug, Ozempic. This approval is expected to introduce a more affordable alternative to the market.
29 Apr, 15:14 — 29 Apr, 15:14
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: capital-bg · 29 Apr, 09:47|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning
